Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 pediatric pharmacokinetics and safety study of etavopivat in sickle cell disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Forma Therapeutics, Inc. | Conditions: Sickle Cell Disease | Phase 2 | Status: RECRUITING